Voyager Therapeutics, Inc.
Ticker: VYGR
| Insider | Title |
|---|---|
| Alfred Sandrock | President and CEO, Director |
| Biosciences Inc Neurocrine | 10% or greater ownership |
| Capital, Llc Ecor1 | 10% or greater ownership |
| Catherine J Mackey | Director |
| George A Scangos | Director |
| Glenn Pierce | Director |
| Gp Iii, Llc Trv | 10% or greater ownership |
| Grace Colon | Director |
| James A Geraghty | Director |
| Jude Onyia | Director |
| Julie Burek | VP, Finance |
| Mark J Levin | Director, 10% or greater ownership |
| Michael J Higgins | Director |
| Nancy Vitale | Director |
| Nathan D. Jorgensen | Chief Financial Officer |
| Peter P. Pfreundschuh | Chief Financial Officer |
| Robert I Tepper | 10% or greater ownership |
| Robert W. Hesslein | Senior VP General Counsel |
| Robin Swartz | Chief Operating Officer |
| Rock Ventures Gp Iii, L.p. Third | 10% or greater ownership |
| Rock Ventures Iii, L.p. Third | 10% or greater ownership |
| Sandell Jacquelyn Fahey | Chief Legal Officer |
| Steven Hyman | Director |
| Steven M Paul | Director |
| Toby Ferguson | Chief Medical Officer |
| Todd Alfred Carter | Chief Scientific Officer |